PCCTC Innovation Featured at Biocom California’s “Innovations in Oncology Clinical Trial Design” Forum

Nov 6

Written By Kristofer Prepelica, PhD

Kristofer Prepelica, PhD

Prespecified Third Interim Analysis of the DARolutamide ObservationaL (DAROL) Study